Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Other Non-Current Assets (2020 - 2025)

RxSight (RXST) has disclosed Other Non-Current Assets for 6 consecutive years, with $590000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 63.89% year-over-year to $590000.0, compared with a TTM value of $590000.0 through Dec 2025, up 63.89%, and an annual FY2025 reading of $590000.0, up 63.89% over the prior year.
  • Other Non-Current Assets was $590000.0 for Q4 2025 at RxSight, up from $536000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $761000.0 in Q4 2022 and bottomed at $25000.0 in Q3 2022.
  • Average Other Non-Current Assets over 5 years is $469473.7, with a median of $536000.0 recorded in 2025.
  • The sharpest move saw Other Non-Current Assets plummeted 95.54% in 2022, then soared 2744.0% in 2023.
  • Year by year, Other Non-Current Assets stood at $114000.0 in 2021, then surged by 567.54% to $761000.0 in 2022, then dropped by 6.57% to $711000.0 in 2023, then crashed by 49.37% to $360000.0 in 2024, then soared by 63.89% to $590000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for RXST at $590000.0 in Q4 2025, $536000.0 in Q3 2025, and $750000.0 in Q2 2025.